These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19473027)

  • 1. Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.
    Guerrini R; Camarda V; Trapella C; Caló G; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    J Med Chem; 2009 Jul; 52(13):4068-71. PubMed ID: 19473027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.
    Guerrini R; Camarda V; Trapella C; Calò G; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    J Med Chem; 2009 Jan; 52(2):524-9. PubMed ID: 19113861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies.
    Ruzza C; Rizzi A; Camarda V; Pulga A; Marzola G; Filaferro M; Novi C; Ruggieri V; Marzola E; Vitale G; Salvadori S; Guerrini R; Calo' G
    Peptides; 2012 Apr; 34(2):404-11. PubMed ID: 22342393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat.
    Cifani C; Micioni Di Bonaventura MV; Cannella N; Fedeli A; Guerrini R; Calo G; Ciccocioppo R; Ubaldi M
    Peptides; 2011 Jan; 32(1):44-50. PubMed ID: 20971145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1.
    Camarda V; Ruzza C; Rizzi A; Trapella C; Guerrini R; Reinscheid RK; Calo G
    Peptides; 2013 Oct; 48():27-35. PubMed ID: 23911665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of human neuropeptide S analogues modified in position 2.
    Camarda V; Trapella C; Calo G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    J Med Chem; 2008 Feb; 51(3):655-8. PubMed ID: 18181564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation.
    Filaferro M; Novi C; Ruggieri V; Genedani S; Alboni S; Malagoli D; Caló G; Guerrini R; Vitale G
    Peptides; 2013 Jan; 39():16-20. PubMed ID: 23142110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
    Camarda V; Rizzi A; Ruzza C; Zucchini S; Marzola G; Marzola E; Guerrini R; Salvadori S; Reinscheid RK; Regoli D; Calò G
    J Pharmacol Exp Ther; 2009 Feb; 328(2):549-55. PubMed ID: 18971372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
    Guerrini R; Salvadori S; Rizzi A; Regoli D; Calo' G
    Med Res Rev; 2010 Sep; 30(5):751-77. PubMed ID: 19824051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide S receptor: recent updates on nonpeptide antagonist discovery.
    Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R; Cristalli G
    ChemMedChem; 2011 Jul; 6(7):1163-71. PubMed ID: 21452188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.
    Roth AL; Marzola E; Rizzi A; Arduin M; Trapella C; Corti C; Vergura R; Martinelli P; Salvadori S; Regoli D; Corsi M; Cavanni P; Caló G; Guerrini R
    J Biol Chem; 2006 Jul; 281(30):20809-20816. PubMed ID: 16720571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor.
    Ruzza C; Asth L; Guerrini R; Trapella C; Gavioli EC
    Neuropharmacology; 2015 Oct; 97():1-6. PubMed ID: 25979487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide S receptor ligands: a patent review (2005-2016).
    Ruzza C; Calò G; Di Maro S; Pacifico S; Trapella C; Salvadori S; Preti D; Guerrini R
    Expert Opin Ther Pat; 2017 Mar; 27(3):347-362. PubMed ID: 27788040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I.
    Bernier V; Stocco R; Bogusky MJ; Joyce JG; Parachoniak C; Grenier K; Arget M; Mathieu MC; O'Neill GP; Slipetz D; Crackower MA; Tan CM; Therien AG
    J Biol Chem; 2006 Aug; 281(34):24704-12. PubMed ID: 16790440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Activity Relationship Studies on Oxazolo[3,4-
    Albanese V; Ruzza C; Marzola E; Bernardi T; Fabbri M; Fantinati A; Trapella C; Reinscheid RK; Ferrari F; Sturaro C; Calò G; Amendola G; Cosconati S; Pacifico S; Guerrini R; Preti D
    J Med Chem; 2021 Apr; 64(7):4089-4108. PubMed ID: 33733768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor.
    Tancredi T; Guerrini R; Marzola E; Trapella C; Calo G; Regoli D; Reinscheid RK; Camarda V; Salvadori S; Temussi PA
    J Med Chem; 2007 Sep; 50(18):4501-8. PubMed ID: 17696420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity study at positions 3 and 4 of human neuropeptide S.
    Camarda V; Trapella C; Calo' G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    Bioorg Med Chem; 2008 Oct; 16(19):8841-5. PubMed ID: 18793857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice.
    Han RW; Chang M; Peng YL; Qiao LY; Yin XQ; Li W; Wang R
    Peptides; 2009 Jul; 30(7):1313-7. PubMed ID: 19540430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
    Leonard SK; Dwyer JM; Sukoff Rizzo SJ; Platt B; Logue SF; Neal SJ; Malberg JE; Beyer CE; Schechter LE; Rosenzweig-Lipson S; Ring RH
    Psychopharmacology (Berl); 2008 May; 197(4):601-11. PubMed ID: 18311561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide S promotes maintenance of newly formed dendritic spines and performance improvement after motor learning in mice.
    Li C; Wu XJ; Li W
    Peptides; 2022 Oct; 156():170860. PubMed ID: 35970276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.